Pyramid Pharma Services Announces Drug Product Manufacturing Agreement for Phio Pharmaceuticals’ Lead Oncology Candidate
Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy for skin cancers COSTA MESA, CA, UNITED STATES, April 8, 2026 /EINPresswire.com/ -- Pyramid Pharma Services, a U.S.-based …